Dr. Alan Stolier, MD, FACS, clinical breast oncologist, shares his expert medical perspective with a series of educational and scientific articles.
Low carbohydrate has been and is mostly used for weight loss. However, there may be a relationship between postoperative breast cancer and breast cancer-specific survival and overall survival. …
Radiation has been shown to be advantageous, particularly in women undergoing breast-conserving surgery as well as many having mastectomy with more advanced disease. …
The regulation of progesterone receptor (PR) expression is governed by the estrogen receptor (ER), while PR, in turn, affects ER expression. The presence of PR in a tumor indicates that the ERα pathway is active and functioning normally, and PR plays a critical role in maintaining cell integrity, growth, and proliferation. …
Looking ahead, it seems that genetics will continue to play a crucial role beyond simply assessing risk and treating known oncogenes. In my view, the ultimate goal is to develop genetic treatments for existing cancers….
AI tools increase diagnostic accuracy, improve breast cancer risk assessment, and predict response to cancer therapy. AI is also being used to improve image reconstruction so that higher quality images can be obtained with lower radiation doses, as well as shorter acquisition times for breast MRI. …
The question remains whether the risk of breast cancer in BRCA1/BRCA2 mutation carriers beyond age 60 is enough to justify intensive screening or prophylactic surgery. …
After a woman has developed an initial primary breast cancer, the risk of a second breast cancer takes on greater importance as it relates to surveillance and having the potential to impact the initial primary surgical approach. …
Most genetic testing and preventive measures are carried out in women less than 50 years. A multinational, multi-institutional group of scientists studied BRCA1 and BRCA2-positive patients from ages 50 to 75 to estimate the cumulative risk of all cancers. …
Current guidelines recommend only clinician visits to detect breast cancer recurrence following initial treatment. Imaging is only recommended for those patients demonstrating signs or symptoms of recurrence….
Current guidelines recommend only clinician visits to detect breast cancer recurrence following initial treatment. Imaging is only recommended for those patients demonstrating signs or symptoms of recurrence….